GenomOncology enables precision medicine by translating next generation sequencing data into actionable information for clinicians and researchers. As the bottleneck of cancer molecular diagnostics has moved from data acquisition to data interpretation, GenomOncology has developed a proprietary technology platform that captures critical findings for the cancer researcher or clinical oncologist and produces a robust, actionable report in less than a day. Find out more here.

© 2019 Venture for America. All Rights Reserved.
Website by Briteweb